Precigen (PGEN) Total Liabilities (2012 - 2026)
Precigen's (PGEN) quarterly Total Liabilities came in at $118.4 million in Q1 2026, up 4.47% year-on-year from $113.3 million in Q1 2025, and down 12.04% on a QoQ basis from $134.6 million in Q4 2025.
Precigen (PGEN) Total Liabilities (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Total Liabilities data on file, last reported at $118.4 million in Q1 2026.
- On a quarterly basis, Total Liabilities rose 4.47% year-over-year to $118.4 million in Q1 2026; TTM through Mar 2026 was $118.4 million, a 4.47% increase from a year earlier, with the FY2025 full-year figure at $134.6 million, up 71.38% from the prior year.
- Total Liabilities for Q1 2026 stood at $118.4 million, down from $134.6 million in the prior quarter.
- Over the last five years, Total Liabilities for PGEN reached as high as $265.6 million in Q2 2022 and fell as low as $28.1 million in Q3 2024.
- Historically, Total Liabilities has averaged $99.2 million across 5 years, with a median of $89.7 million in 2022.
- Across the five-year window, Total Liabilities sank 84.44% in 2023 and surged 360.52% in 2025, its largest moves.
- Year by year, Total Liabilities stood at $89.7 million in 2022, then plunged by 63.73% to $32.5 million in 2023, then soared by 141.31% to $78.5 million in 2024, then soared by 71.38% to $134.6 million in 2025, then dropped by 12.04% to $118.4 million in 2026.
- Per Business Quant data, the three most recent Total Liabilities figures were $118.4 million in Q1 2026, $134.6 million in Q4 2025, and $129.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | 118.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 118.39 Mn |
| Dec 31, 2025 | 134.59 Mn |
| Sep 30, 2025 | 129.40 Mn |
| Jun 30, 2025 | 107.79 Mn |
| Mar 31, 2025 | 113.33 Mn |
| Dec 31, 2024 | 78.54 Mn |
| Sep 30, 2024 | 28.10 Mn |
| Jun 30, 2024 | 29.99 Mn |
| Mar 31, 2024 | 37.83 Mn |
| Dec 31, 2023 | 32.55 Mn |
| Sep 30, 2023 | 43.01 Mn |
| Jun 30, 2023 | 41.32 Mn |
| Mar 31, 2023 | 57.41 Mn |
| Dec 31, 2022 | 89.72 Mn |
| Sep 30, 2022 | 116.71 Mn |
| Jun 30, 2022 | 265.57 Mn |
| Mar 31, 2022 | 261.73 Mn |
| Dec 31, 2021 | 252.51 Mn |
| Sep 30, 2021 | 245.65 Mn |
| Jun 30, 2021 | 243.38 Mn |